Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Details) - Schedule of Summarizes Activity for Stock Options Under All Plans

v3.24.1
Stock-Based Compensation (Details) - Schedule of Summarizes Activity for Stock Options Under All Plans
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Share-Based Payment Arrangement, Disclosure [Abstract]    
Number of Shares Underlying Outstanding Options, Options granted | shares   8,989,487
Weighted-Average Exercise Price, Options granted | $ / shares   $ 0.75
Weighted Average Remaining Contractual Term, Options granted   9 years 7 months 9 days
Aggregate Intrinsic Value, Options granted | $   $ 1,072
Number of Shares Underlying Outstanding Options, Options forfeited | shares   (21,882)
Weighted-Average Exercise Price, Options forfeited | $ / shares   $ 4.39
Aggregate Intrinsic Value, Options forfeited | $  
Number of Shares Underlying Outstanding Options, Options exercised | shares   (8,189)
Weighted-Average Exercise Price, Options exercised | $ / shares   $ 3.27
Aggregate Intrinsic Value, Options exercised | $  
Number of Shares Underlying Outstanding Warrants, Outstanding at ending balance | shares 1,342,670 10,302,086
Weighted- Average Exercise Price, Outstanding at ending balance | $ / shares $ 2.75 $ 1
Weighted- Average Remaining Contractual Term (in Years), Outstanding at ending balance 8 years 5 months 19 days 9 years 4 months 2 days
Aggregate Intrinsic Value, Outstanding at ending balance | $ $ 52 $ 1,196
Number of Shares Underlying Outstanding Options, Options vested and exercisable | shares   915,187
Weighted-Average Exercise Price, Options vested and exercisable | $ / shares   $ 3.02
Weighted-Average Remaining Contractual Term (in Years), Options vested and exercisable   7 years 1 month 9 days
Aggregate Intrinsic Value, Outstanding, Options vested and exercisable | $   $ 96